Science Explorer Back to mapMap
Discussion
Researcher · Leo Pharma (Australia) · Australia

Ming-Chen Yang

Ming-Chen Yang publishes mostly in Molecular Biology, Immunology and Oncology, on topics such as Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research and Cancer Research and Treatments.

ORCID 0000-0001-5330-6984 OpenAlex
World rank
#3,437,290
of 7,710,434 ranked researchers
Rank in Australia
#90,171
of 140,210
Works
20
Citations
309
Citations per work
15.5
h-index
8
i10-index 7Top 87% in Molecular Biology
Ming-Chen Yang

What does Ming-Chen Yang research?

Ming-Chen Yang's work is mostly in Biochemistry, Genetics and Molecular Biology (37%), Medicine (22%), Immunology and Microbiology (12%).

Life Sciences: 10 works · 48.9% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 36.7% of their workMolecular Biology: 5 works · 26.5% of their workBiotechnology: 1 works · 6.1% of their workCell Biology: 1 works · 4.1% of their workImmunology and Microbiology: 2 works · 12.2% of their workImmunology: 2 works · 12.2% of their workEverything else: 6 works · 28.7% of their workHealth Sciences: 4 works · 22.4% of their workMedicine: 4 works · 22.4% of their workOncology: 2 works · 12.2% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 10.2% of their workTHEIR WORKMing-Chen Yang20works
Life Sciences49%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology736.7%
    2. Immunology and Microbiology212.2%
  2. Everything else628.7%
    1. Medicine422.4%
  1. 1Molecular Biology26% of their works
  2. 2Immunology12% of their works
  3. 3Oncology12% of their works
  4. 4Radiology, Nuclear Medicine and Imaging10% of their works
  5. 5Biotechnology6% of their works
  6. 6Cell Biology4% of their works

Research topics

Which keywords describe Ming-Chen Yang's research?

The keywords of their largest research topics: Glycosylation, Cancer, Glycans, Immune System, Immunotherapy, Fc Receptors, Therapeutic Antibodies and Angiogenesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Glycosylation112 topics
  2. Cancer103 topics
  3. Glycans61 topic
  4. Immune System61 topic
  5. Immunotherapy62 topics
  6. Fc Receptors51 topic
  7. Therapeutic Antibodies51 topic
  8. Angiogenesis42 topics
  9. Immune Regulation42 topics
  10. Inflammation42 topics
  11. Bacterial Therapy31 topic
  12. Pancreatic Cancer31 topic
  13. Surgical Complications31 topic
  14. Tumor Targeting31 topic
  15. CD4721 topic
  16. Cell Adhesion21 topic
  17. Cell Cycle21 topic
  18. Galectins21 topic
  19. Integrins21 topic
  20. Macrophage Activation21 topic
  21. apoptotic cells21 topic
  22. p5321 topic

Where does Ming-Chen Yang work?

Ming-Chen Yang's main affiliation in the publication record is Leo Pharma (Australia), Australia.

How many publications and citations does Ming-Chen Yang have?

OpenAlex counts 20 works and 309 citations for Ming-Chen Yang, an h-index of 8, ranking #3,437,290 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ming-Chen Yang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.